Method Development for Laser-Diffraction Particle-Size Analysis - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Method Development for Laser-Diffraction Particle-Size Analysis
The author examines the process of method development, with reference to ISO 13320:2009 and relevant monographs from the United States and European pharmacopoeias.


Pharmaceutical Technology
pp. 100-106

References

1. ISO 13320:2009 Particle Size Analysis—Laser Diffraction Methods. Part 1: General Principles (2009).

2. USP30–NF25 General Chapter <429>, "Light Diffraction Measurement of Particle Size," pp. 1235–1241.

3. ISO 14488:2007 Particulate materials—Sampling and sample splitting for the determination of particulate properties.

4. Application note MRK373: The Use of Zeta Potential Measurements for Improving Dispersion During Particle Size Measurements, http://www.malvern.com/appnote_particle_size_determination, accessed Sept. 18, 2010.

5. ISO 14887:2000 Sample Preparation—Dispersing procedures for powders in liquids (2000).

6. Ph.Eur. 6.6 General Chapter 2.9.31, "Laser Diffraction Measurement of Particle Size," (EDQM, Strasbourg, France) p. 5103.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
30%
Breakthrough designations
9%
Protecting the supply chain
39%
Expedited reviews of drug submissions
9%
More stakeholder involvement
13%
View Results
Jim Miller Outsourcing Outlook Jim Miller Health Systems Raise the Bar on Reimbursing New Drugs
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerThe Mainstreaming of Continuous Flow API Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler Industry Seeks Clearer Standards for Track and Trace
Siegfried Schmitt Ask the Expert Siegfried SchmittData Integrity
Sandoz Wins Biosimilar Filing Race
NIH Translational Research Partnership Yields Promising Therapy
Clusters set to benefit from improved funding climate but IP rights are even more critical
Supplier Audit Program Marks Progress
FDA, Drug Companies Struggle with Compassionate Use Requests
Source: Pharmaceutical Technology,
Click here